After announcing round after round of layoffs, AstraZeneca CEO David Brennan announced Thursday that he, too, was joining the ranks of the unemployed. His announcement was a bookend to the first quarter results which showed the oncoming pain of a very steep patent black hole: sales were $7.3 billion for the quarter ended March 31, an 11% drop compared to sales for the same period last year.